M&A Deal Summary |
|
|---|---|
| Date | 2005-02-18 |
| Target | EKOS |
| Sector | Medical Products |
| Buyer(s) | EGS Healthcare Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 135M USD |
| Size | Small |
| Type | Sector Focused |
EGS Healthcare Capital Partners is a specialist private equity firm focused on investments in the healthcare sector. Specific areas of interest include biotechnology, specialty pharmaceutical, and medical device companies. EGS typically invests in late-stage private and emerging public companies with promising products. EGS prefers to lead investments with an initial commitment of $5 million per transaction. The Firm generally seeks board representation. EGS Healthcare Partner was formed in 1999 and is based in Rowayton, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector: Medical Products M&A | 4 of 4 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 1 of 1 |
| State: Washington M&A | 1 of 1 |
| Country: United States M&A | 6 of 6 |
| Year: 2005 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-10-01 |
Transport Pharmaceuticals
Framingham, Massachusetts, United States Transport Pharmaceuticals is a privately held company developing a proprietary iontophoretic delivery platform for the treatment of dermatological diseases. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-06-30 |
Peninsula Pharmaceuticals
Alameda, California, United States Peninsula Pharmaceuticals, Inc. is a pharmaceutical company focuses on licensing, developing, and commercializing anti-infective products for the treatment of life-threatening infections. |
Sell | $245M |
